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ABSTRACT
The gut microbiota plays an integral role in human health and its dysbiosis is associated with many chronic diseases. There
are still large gaps in understanding the host and environmental factors that directly regulate the gut microbiota, and few
effective strategies exist to modulate the microbiota in therapeutic applications. Recent reports suggest that certain
microRNAs (miRNAs) released by mammalian cells can regulate bacterial gene expression to influence the microbiome
composition and propose extracellular vesicles as one natural mechanism for miRNA transport in the gut. These new
findings interface with a burgeoning body of data showing that miRNAs are present in a stable form in extracellular
environments and can mediate cell-to-cell communication in mammals. Here, we review the literature on RNA-mediated
modulation of the microbiome to bring cross-disciplinary perspective to this new type of interaction and its potential
implications in biology and medicine.
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THE GUT MICROBIOTA AND ITS MODULATION
The mammalian gastrointestinal (GI) tract hosts a complex and
diverse population of microorganisms collectively known as the
gut microbiota. The number of microorganisms inhabiting the
GI tract has been estimated to be 1013–1014 and the gut micro-
biome contains over 100 times as many genes as the human
genome (Thursby and Juge 2017). The gut microbiota contributes
to host health through various physiological functions such as
maintaining intestinal barrier (Natividad and Verdu 2013), mod-
ulating the host’s energy metabolism (Cani et al. 2019), protect-
ing against infection by pathogenic bacteria (Buffie et al. 2015)
and shaping host immunity (Wu et al. 2010; Gaudet et al. 2015).
Many studies suggest that the maintenance of gut bacterial
community structure is important for health and that dysbio-
sis of the gut microbiota is associated with numerous human
diseases, including inflammatory bowel diseases (Nishino et al.
2018), obesity (Walters, Xu and Knight 2014), diabetes mellitus
(Wen et al. 2008) and GI cancers (Serban 2014).
There is a growing need for new approaches to specifically
manipulate the gut microbiota, and there is also increasing
interest in understanding the natural host mechanisms involved
in its regulation. It is well known that host-derived products,
such as mucus, antimicrobial peptides and IgA, produced by
the intestinal epithelial cells, can encourage the growth of some
microbial species and inhibit that of others (Suzuki et al. 2004;
Carvalho et al. 2012). In the last 5 years, several papers have
shown that mammalian microRNAs (miRNAs) can influence the
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composition and activity of the gut bacteria in a specific way,
for example through direct RNA–RNA interactions with bacterial
genes. These findings interface with a burgeoning body of liter-
ature showing that small RNAs, including miRNAs, can operate
beyond the cell in which they derive in mammals, through trans-
port in extracellular vesicles (EVs) or other carriers.
miRNAs: FUNCTION AND REGULATION IN THE
GUT
There are three predominant classes of small RNA in eukary-
otes that mediate gene regulation and genome defence: small
interfering RNAs, PIWI-associated RNAs and miRNAs (Kutter
and Svoboda 2008). Of these classes, miRNAs are the most well
studied in mammals for their roles in development and disease
(Kloosterman and Plasterk 2006). miRNAs derive from endoge-
nous genes that are typically transcribed by RNA polymerase
II into primary miRNA transcripts that undergo processing by
Drosha and other cofactors in the nucleus (Pasquinelli 2012).
This processing produces the pre-miRNAs (∼60–70 nucleotides
in length) that are transported to the cytoplasm by Exportin 5
where they are further processed by Dicer, which removes the
loop region from pre-miRNAs. One strand of the resulting duplex
is bound by an Argonaute (Ago) protein to form the RNA-induced
silencing complex (RISC). Within RISC, the miRNA serves as
the guide to bind to specific messenger RNA targets through
sequence complementarity and this results in either cleavage
of the mRNA or inhibition of translation (Bartel 2018).
Many reports have now demonstrated the importance
of miRNAs in gut function. For example, fewer goblet cells,
impaired nutrient absorption and barrier function were
observed in mice in which Dicer was ablated from intestinal
epithelial cells (McKenna et al. 2010). The fate of human intesti-
nal epithelial cells was also shown to be directly regulated by
transfection of synthetic miRNA mimics or inhibitors (Dal-
masso et al. 2010). Moreover, miRNA expression profiles within
intestinal cells have been shown to change during various
intestinal diseases, and some of the miRNAs are likely to be
causative agents in disease progression and development. For
example, the level of miR-21 increased in colonic tissue from
active ulcerative colitis and Crohn’s disease, and its pathogenic
role was confirmed in miR-21 knockout mice (Wu et al. 2008; Shi
et al. 2013; Yang et al. 2013).
miRNAs also play a role in the ability of intestinal cells to
sense and respond to changes in the environment. For exam-
ple, intestinal miRNA levels are modulated when exposed to
high amounts of dietary lipids (Gil-Zamorano et al. 2020), and the
presence or absence of the microbiome directly affects miRNA
expression in intestinal cells (Dalmasso et al. 2011; Singh et al.
2012). miRNA expression levels were further shown to be altered
in a highly cell type-specific manner, with the strongest dereg-
ulation in stem cells, suggesting important roles of miRNAs in
regulating intestinal homeostasis (Peck et al. 2017).
EXTRACELLULAR miRNAs AND RNA
COMMUNICATION IN THE GUT
The above work suggests that the biogenesis and function of
miRNAs may be closely tied to sensing changes in the intesti-
nal environment. At the same time, miRNAs are also now recog-
nized to be released into the environment, with scope to act out-
side of the cells in which they derive. Extensive literature in the
last 15 years has shown that miRNAs can be detected in a cell-
free form in different body fluids (Murillo et al. 2019). Further-
more, miRNAs are stable and can be reliably detected in faeces
from human and mice (Ahmed et al. 2009; Wu et al. 2012), provid-
ing a noninvasive method to sample gut luminal miRNAs in dif-
ferent contexts. For example, the levels of miR-21 and miR-92a
were significantly higher in the stool of patients with colorectal
cancer compared with healthy controls (Wu et al. 2012). There
is an increasing interest in using faecal miRNAs as noninvasive
markers of intestinal malignancies (Yau et al. 2019).
Beyond their biomarker potential, miRNAs and other classes
of extracellular small RNA have also been reported to participate
in communication between different organisms and species
(Claycomb, Abreu-Goodger and Buck 2017). The relative abun-
dance and stability of mammalian miRNAs in the gut lumen
therefore lead to the question of whether these could modulate
gene targets in other organisms in the gut.
EVIDENCE OF DIRECT miRNA–BACTERIA
INTERACTIONS IN THE GUT
Several recent studies have reported direct RNA–RNA interac-
tions between host miRNAs and bacterial genes in the gut
(Table 1), based on a combination of in vivo genetic experiments
in mice and in vitro validation experiments.
Liu et al. (2016) used Dicer knockout mice in a first demon-
stration that the deficiency of miRNAs in intestinal epithelial
cells caused an imbalanced gut microbiota, which can then be
restored by transplantation of wild-type faecal miRNAs (where
the native RNA is extracted from faeces and administrated
to mice by gavage). To explore whether specific miRNAs can
directly interact with gut bacteria, the authors selected two
important gut bacteria, Fusobacterium nucleatum and Escherichia
coli, to predict their potential interacting miRNAs by sequence
similarity. By culturing the strains with synthesized miRNAs in
vitro, they found that miRNA-515-5p can stimulate F. nucleatum
growth and that miRNA-1226-5p can stimulate E. coli growth.
The expression levels of predicted miRNA targets in these two
strains were also found to be increased in response to the syn-
thetic RNA. In a subsequent study, the same authors showed
that miR-30d, which is enriched in the faeces of animals with
experimental autoimmune encephalomyelitis (EAE), can pro-
mote the growth of Akkermansia muciniphila by increasing the
expression of β-galactosidase (Liu et al. 2019). These examples
suggest that host miRNA interactions with bacterial transcripts
can lead to an increase in bacterial gene expression and bac-
terial growth. A more recent study suggests that miRNAs can
also suppress bacterial growth. In particular, the composition of
gut microbiota in miR-21 knockout mice was characterized by an
increase in Lactobacillus and incubation of synthetic miR-21 with
Lactobacillus reuteri led to reduced growth (Santos et al. 2020).
IMPLICATIONS AND QUESTIONS
The above studies suggest that specific mammalian miRNAs
are naturally transported into some bacterial cells, where the
miRNA forms a direct RNA–RNA interaction with a bacterial
gene, resulting in changes in the microbiome with phenotypic
effects in intestinal health. The potential impact of these find-
ings is immense, since this suggests that intestinal miRNAs are
an integral part of how the microbiome is regulated. Further-
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Table 1. Reported miRNA–bacteria interactions in the gut.
miRNA Bacteria species Target transcript Effect on bacteria Reference
miR-1226-5p Escherichia coli yegH mRNA Promotion Liu et al. (2016)
miR-515-5p Fusobacterium nucleatum 16S rRNA Promotion Liu et al. (2016)
miR-30d Akkermansia muciniphila β-Galactosidase mRNA Promotion Liu et al. (2019)
miR-21 Lactobacillus reuteri Unknown Inhibition Santos et al. (2020)
one could envision this as a new, programmable method to dic-
tate changes to the composition or activity of the microbiome.
Yet some big questions remain in terms of how miRNA–bacteria
interactions are specified and controlled, how the RNA–RNA
interactions evolve and, ultimately, whether and how synthetic
RNA is a viable and safe strategy for microbiome manipulation
(Fig. 1). Here, we attempt to discuss these questions and provide
some directions for future study.
APPROACHES TO IDENTIFY SPECIFIC
miRNA–BACTERIA INTERACTIONS
Since there are thousands of miRNAs as well as bacterial
species/strains in the gut, it is a daunting prospect to system-
atically determine or predict which miRNA–bacteria interac-
tions occur. The strategy used by Liu et al. (2019) was to iden-
tify miRNAs that are altered in faeces in different disease con-
texts and to link this to changes in the microbiome. For example,
A. muciniphila was found to be increased in the faeces from EAE
mice compared with controls, and miR-30d was also enriched
in faeces from EAE mice (Liu et al. 2019). However, one could
imagine a lot of false positives in this approach, and it should
be noted that the level of a miRNA in faeces is not a direct proxy
for miRNAs internalized by bacteria, since dead host cells and
extracellular luminal miRNAs will also be present. Nonetheless,
Liu et al. (2019) showed that miR-30d could directly impact the
growth of A. muciniphila by culturing the strain in the presence
of synthetic miR-30d in vitro and also through oral administra-
tion of synthetic miR-30d to mice in vivo. The miRNA-dependent
increase in bacterial growth was not observed using scrambled
miRNA sequence controls (Liu et al. 2019).
miRNA–bacteria interactions can also be inferred based on
studies in miRNA knockout mice, as demonstrated by Santos
et al. (2020). In the miR-21 knockout mouse, Lactobacillus was
found to be significantly increased in the small intestinal lumen
when compared with wild-type animals (Santos et al. 2020).
Although ablation of the miRNA could also indirectly affect the
microbiome (e.g. through altered host cell populations and func-
tions), the authors showed that synthetic miR-21 directly sup-
pressed the growth of Lactobacillus by in vitro assays. Sequence
specificity was demonstrated in this study too, since the scram-
bled miR-21 sequence did not show effects. Ultimately, under-
standing the host transport mechanisms of miRNAs could help
shed light on whether and how there is specificity, for example,
in which bacteria can internalize various extracellular miRNAs,
and what machinery is required within the bacteria for the miR-
NAs to be functional.
TRANSFER MECHANISM FOR miRNA INTO
BACTERIA CELLS: A ROLE OF EXTRACELLULAR
VESICLES?
The published studies described above have cultured specific
bacteria with synthetic miRNAs in vitro to show that naked
miRNAs can enter bacteria and uptake or activity is sequence
specific. However, the natural miRNA uptake mechanism in the
gut environment is not known, nor is it clear whether only spe-
cific bacteria internalize RNA.
In mammals, EVs are the most well-studied mechanism for
miRNA stabilization and transfer between cells. There are three
general classes of EVs, depending on their biogenesis: (i) exo-
somes (generally 50–100 nm in size), which are of endosomal
origin and derive from multivesicular bodies; (ii) microvesicles
(generally 100–1000 nm in size), which bud off the plasma mem-
brane; and (iii) apoptotic bodies (generally 50–5000 nm in size),
which are generated when cells undergo apoptosis (Colombo,
Raposo and Théry 2014). Several key studies demonstrated that
intestinal epithelial cells release exosomes, suggesting these are
involved in antigen presentation (Van Niel et al. 2001, 2003). How-
ever, we now know that exosomes and other classes of EVs
also contain RNAs, including miRNAs (Veziroglu and Mias 2020).
Seminal work by Valadi et al. (2007) showed that miRNAs can
be transported from one mast cell to another via exosomes.
Microvesicles derived from tumours were shown to deliver miR-
NAs to CD4+ T cells and thereby increase the number of reg-
ulatory T cells, promoting tumour growth (Yin et al. 2014). EVs
can also mediate communication between different species in
the gut. For example, the GI nematode Heligmosomoides polygyrus
releases miRNA-containing EVs that can be internalized by host
mouse cells and modulate innate immunity during infection
(Buck et al. 2014).
EVs therefore represent a potential transport mechanism
for mammalian miRNAs in the gut, and there is some evi-
dence that mammalian EVs interact with bacteria, with diverse
functional outcomes. For example, EVs released from the res-
piratory epithelium during respiratory viral infection interact
with Pseudomonas aeruginosa to provide nutrients and promote
biofilms (Hendricks et al. 2021). EVs released from neutrophils
or macrophages have also been shown to have antimicrobial
activities (Timár et al. 2013; Garcia-Martinez et al. 2019). This
work sets precedent that host EVs can impact bacteria and may
directly transport host molecules into some species. Interest-
ingly, although Liu et al. (2016) demonstrated that synthetic miR-
NAs can enter bacteria in vitro (without cofactors), they also
showed that EVs containing miRNAs were present in human and
mouse faecal samples. Yet the question of specificity remains:
Do all bacteria internalize EVs? Are there ligand/receptor inter-
actions that dictate which bacteria internalize these? Intrigu-
ingly, a recent paper showed that EVs from ginger plant can
also transport miRNAs into Lactobacillus rhamnosus, and pro-
posed that the lipid content of the EVs was important for uptake
and potentially specificity (Teng et al. 2018). Given the ubiq-
uity of EVs from organisms in the gut, as well as potential
dietary sources of EVs, it will be important to test the breadth
of cross-species transfer of miRNA by EVs and understand the
underlying properties that define specificity. It remains possi-
ble that other types of gut inhabitants (e.g. fungi) could also
internalize host miRNAs. There is little information of this
type of interaction in mammalian systems but a burgeoning
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Figure 1. Knowledge gaps in miRNA–bacteria interactions.
The other more unexplored stabilization and transport
mechanism for mammalian miRNAs is RNA-binding proteins.
miRNAs have been reported to be delivered by high-density
lipoprotein to recipient cells and to regulate the expression of
target genes (Vickers et al. 2011). miRNAs are also found bound to
Ago proteins in human plasma and serum, and this association
is proposed to play a critical role in stabilizing miRNA (Arroyo
et al. 2011; Turchinovich et al. 2011). Whether and how bacteria
internalize host RNA–protein complexes remains unexplored.
FUNCTIONAL INTEGRATION OF miRNAs IN
BACTERIA
In mammals, it is assumed that miRNAs only function through
association with an Ago protein, where their role is to guide this
protein to a nucleic acid target with sequence complementar-
ity. From a mechanistic standpoint, therefore, it is very relevant
to understand whether Ago moves with miRNAs into bacteria.
Several reports have demonstrated that Ago2 is transported into
mitochondria, which is evolutionarily related to bacteria, and
miRNA–Ago2 complexes can enhance mitochondrial translation
(Zhang et al. 2014). Currently, there are no data on whether Ago
proteins can enter bacteria in the gut, either in a vesicle-free
form or within EVs.
However, it also remains possible that internalized miRNAs
could interact with bacterial RNA-binding proteins. It is well
known that bacteria use their own small RNAs to regulate gene
expression and the best characterized mechanism involves the
bacterial chaperone protein Hfq (Soper et al. 2010) that recruits
the endoribonuclease RNase E (Morita and Aiba 2011). Since sev-
eral reports have shown that culturing bacteria with synthetic
miRNA mimics in vitro directly impacts bacterial gene expres-
sion (Liu et al. 2019; Santos et al. 2020), it may be important to
consider whether and how miRNAs function with bacterial pro-
tein partners (Layton et al. 2020).
FUTURE PERSPECTIVE
Given the many diverse functions and mechanisms by which
RNA can mediate cellular and organismal biology, it is an excit-
ing prospect to consider RNA functions also in more complex liv-
ing systems. In plants, mobile small RNAs have been shown to be
part of a bidirectional arms race with fungal parasites (Weiberg
et al. 2013; Cai et al. 2018) and plant sRNAs can also regulate
genes in bacterial phytopathogens (Singla-Rastogi et al. 2019).
In honeybees, small RNAs are thought to mediate some of the
caste-determining effects of royal jelly (Zhu et al. 2017) and are
transmissible between organisms and across generations (Maori
et al. 2019). As reviewed here, there are now several reports that
mouse miRNAs can directly influence the growth rate of certain
bacteria and thereby influence the composition and activity of
the microbiome. These findings push forward the idea that RNA
is central to cross-species interactions, and may implicate EVs
as a ubiquitous enabler of RNA-based communication in the
gut. Yet many questions remain regarding how the mammalian
miRNA and bacterial target sites coevolve and what machinery
is required (in each organism) for RNA communication. To
date, only a handful of examples of host–bacteria RNA–RNA
interaction exist, and these may be cherry-picked from a sea of
possibilities. Ultimately, systematic analyses and mechanistic
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which organisms participate in RNA-mediated communication
and how we can harness this mechanism in medicine.
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